The annual reconstitution of the Nasdaq Biotechnology Index is a routine process. While it reflects changes in the index composition, it does not typically have a direct impact on the index's performance.

Inclusion in a major index like the Nasdaq Biotechnology Index often leads to increased visibility and can attract institutional investors who track the index. This can lead to increased demand for the stock, potentially driving up the price.